Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

Impact of Early Life Adversity on Epigenome at Molecular Level Mapped in Macaques

June 18, 2026
Continue Reading
impact-of-early-life-adversity-on-epigenome-at-molecular-level-mapped-in-macaques
Posted inGenetics

Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine

June 18, 2026
Continue Reading
historic-biotech-ipo,-merck,-protillion’s-ai-deal,-testing-a-lassa–rabies-vaccine
Posted inGenetics

IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings

June 18, 2026
Continue Reading
idbs-and-alchemi-agree-to-accelerate-ai-driven-biopharma-regulatory-filings
Posted inBiotechnology

Moderna’s flu candidate sails through FDA advisory committee in unanimous votes

June 18, 2026
Continue Reading
moderna’s-flu-candidate-sails-through-fda-advisory-committee-in-unanimous-votes
Posted inGenetics

China Sets Framework for Advanced Therapeutic Development

June 18, 2026
Continue Reading
china-sets-framework-for-advanced-therapeutic-development
Posted inGenetics

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain

June 18, 2026
Continue Reading
perseverance,-persistence-key-to-car-t-success,-say-ross-prize-winners-carl-june-and-michel-sadelain
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

study-reveals-brain-differences-associated-with-elevated-disordered-eating-in-young-individuals
Posted inBiotechnology

Study Reveals Brain Differences Associated with Elevated Disordered Eating in Young Individuals

January 10, 2025
A significant finding has emerged from recent research conducted by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s…
Read More
novo-holdings-backed-windward-generates-$200m-series-a,-inks-$970m-biobucks-deal-for-clinical-antibody
Posted inBiotechnology

Novo Holdings-backed Windward generates $200M series A, inks $970M biobucks deal for clinical antibody

January 10, 2025
Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970…
Read More
new,-safer,-tb-vaccine-with-bcg-“kill-switch”-protects-mice-and-monkeys
Posted inGenetics

New, Safer, TB Vaccine with BCG “Kill Switch” Protects Mice and Monkeys

January 10, 2025
Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous…
Read More
eli-lilly-pushes-into-pulmonary-fibrosis-with-$99m-deal-for-mediar’s-midphase-prospect
Posted inBiotechnology

Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar’s midphase prospect

January 10, 2025
Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and…
Read More
bausch-+-lomb-pens-$485m-plus-biobucks-pact-with-city-tx-for-rnai-eye-disease-work
Posted inBiotechnology

Bausch + Lomb pens $485M-plus biobucks pact with City Tx for RNAi eye disease work

January 10, 2025
City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder…
Read More
pfizer’s-pd-1-prospect-beats-age-old-incumbent-in-phase-3-bladder-cancer-trial
Posted inBiotechnology

Pfizer’s PD-1 prospect beats age-old incumbent in phase 3 bladder cancer trial

January 10, 2025
Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in bladder…
Read More
biotech-creator-and-china’s-keymed-launch-antibody-company-with-$180m-series-a
Posted inBiotechnology

Biotech creator and China’s Keymed launch antibody company with $180M series A

January 10, 2025
U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed with $180 million in…
Read More
new-us-study-reveals-men-are-over-three-times-more-likely-to-die-from-brain-injuries
Posted inBiotechnology

New US Study Reveals Men Are Over Three Times More Likely to Die from Brain Injuries

January 10, 2025
A recent analysis conducted on U.S. mortality data has shed light on the alarming rates of traumatic brain injuries (TBI)…
Read More
repare-cans-plans-for-phase-3-cancer-combo-trial-in-latest-money-saving-move
Posted inBiotechnology

Repare cans plans for phase 3 cancer combo trial in latest money-saving move

January 10, 2025
Repare Therapeutics is continuing to strip back its pipeline in order to keep the cash flowing to its most promising…
Read More
fifawc:-enhanced-dataset-delivers-in-depth-annotations-and-semantics-for-advancing-group-activity-recognition
Posted inBiotechnology

FIFAWC: Enhanced Dataset Delivers In-Depth Annotations and Semantics for Advancing Group Activity Recognition

January 10, 2025
Revolutionizing Group Activity Recognition with FIFAWC: A New Dataset Unveiled In the fast-evolving world of computer vision, the need for…
Read More

Posts pagination

Previous page 1 … 1,937 1,938 1,939 1,940 1,941 … 1,989 Next page
You May Have Missed
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

fda-clears-dexcom’s-stelo-otc-glucose-monitor-for-use-with-children
Posted inMedical Technology

FDA clears Dexcom’s Stelo OTC glucose monitor for use with children

irhythm-hit-by-cyberattack-that-compromised-patient-data,-says-operations-unaffected
Posted inMedical Technology

iRhythm hit by cyberattack that compromised patient data, says operations unaffected

amid-us-investment-tour,-j&j-makes-$1b-stop-in-florida-to-upgrade-contact-lens-plant
Posted inMedical Technology

Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant

Privacy Policy    Terms

Scroll to Top